These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16489322)

  • 1. Insulin resistance (metabolic) syndrome in children.
    Rosenberg B; Moran A; Sinaiko AR
    Panminerva Med; 2005 Dec; 47(4):229-44. PubMed ID: 16489322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic complications of obesity in childhood and adolescence: more than just diabetes.
    Nathan BM; Moran A
    Curr Opin Endocrinol Diabetes Obes; 2008 Feb; 15(1):21-9. PubMed ID: 18185059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance syndrome in children.
    Scott LK
    Pediatr Nurs; 2006; 32(2):119-24, 143. PubMed ID: 16719421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood obesity in Asian Indians: a burgeoning cause of insulin resistance, diabetes and sub-clinical inflammation.
    Bhardwaj S; Misra A; Khurana L; Gulati S; Shah P; Vikram NK
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():172-5. PubMed ID: 18296330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolically obese normal weight and phenotypically obese metabolically normal youths: the CASPIAN Study.
    Kelishadi R; Cook SR; Motlagh ME; Gouya MM; Ardalan G; Motaghian M; Majdzadeh R; Ramezani MA
    J Am Diet Assoc; 2008 Jan; 108(1):82-90. PubMed ID: 18155992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose and insulin metabolism in obese youth.
    Burgert TS
    Pediatr Endocrinol Rev; 2006 Dec; 3 Suppl 4():555-9. PubMed ID: 17237742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome: definitions, prevalence and management.
    Levesque J; Lamarche B
    J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
    Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
    Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature.
    Türkoglu C; Duman BS; Günay D; Cagatay P; Ozcan R; Büyükdevrim AS
    Obes Surg; 2003 Oct; 13(5):699-705. PubMed ID: 14627463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.
    Correia ML; Rahmouni K
    Diabetes Obes Metab; 2006 Nov; 8(6):603-10. PubMed ID: 17026484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secular trends in variables associated with the metabolic syndrome of North American children and adolescents: a review and synthesis.
    Eisenmann JC
    Am J Hum Biol; 2003; 15(6):786-94. PubMed ID: 14595870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Background and treatment of metabolic syndrome: a therapeutic challenge.
    van Zwieten PA; Mancia G
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):206-14. PubMed ID: 16959752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and the metabolic syndrome.
    Keller KB; Lemberg L
    Am J Crit Care; 2003 Mar; 12(2):167-70. PubMed ID: 12625176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance syndrome and polycystic ovary syndrome: implications for diagnosis and treatment.
    Tan S; Hahn S; Janssen OE
    Panminerva Med; 2005 Dec; 47(4):211-7. PubMed ID: 16489320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiometabolic syndrome in the adolescent.
    Gardner M; Gardner DW; Sowers JR
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():964-8. PubMed ID: 18806711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.